Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector.
Upcoming hearing on the Pfizer/BioNTech vaccine will be livestreamed on YouTube, Facebook and Twitter.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
Advocates claim victory after more than 1,000 people endorse a demand for inclusion.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Intravenous administration allowed the marginally effective BCG vaccination to work better in monkeys.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
People who received the vaccine did, however, show stronger immune responses against the virus.
The search for a safe, effect HIV vaccine continues.
The race continues to find a way to prevent the most common type of dementia that robs millions of the ability to care for themselves.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.